ImmunityBio, Inc.

Nasdaq:IBRX

Biological Products, (No Diagnostic Substances)·SAN DIEGO, CA

CEO

Adcock Richard

CFO

Sachs David C.

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/23/26	→
10-Q	Q3 2025	9/30/25	11/5/25	→
10-Q	Q2 2025	6/30/25	8/5/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	3/3/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
↓

Earnings Releases (8-K)

14 shown

Filed	Period
2/23/26	Q1 FY2026	→
1/15/26	Q4 FY2026	→
11/5/25	Q4 FY2025	→
8/5/25	Q3 FY2025	→
7/25/25	Q2 FY2025	→
5/12/25	Q2 FY2025	→
↓

News (8-K)

66 shown

Filed	Type	Description
2/18/26	Other	Other Events	→
1/26/26	Agreement	Entry into a Material Definitive Agreement	→
1/14/26	Other	Other Events	→
12/29/25	Agreement	Entry into a Material Definitive Agreement	→
12/15/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/12/25	Other	Other Events	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
12/29/25	424B5	424B5	→
7/28/25	424B5	424B5	→
6/23/25	S-8	S-8	→
4/30/25	ARS	ARS	→
4/8/25	424B5	424B5	→
12/12/24	424B5	424B5	→
↓

Filing History(518 filings)

TypeDateAccessionPeriodSize

Feb 26, 2026

0001647994-26-000006FORM 4

Feb 24, 2026

5.3 KB

SCHEDULE 13D/A

Feb 25, 2026

0001193125-26-072879

—

19.9 KB

Feb 24, 2026

0001849739-26-000004FORM 4

Feb 23, 2026

8.3 KB

Feb 24, 2026

0001848899-26-000005FORM 4

Feb 22, 2026

9.1 KB

Feb 24, 2026

0001189020-26-000006FORM 4

Feb 22, 2026

23.9 KB

Feb 24, 2026

0001200637-26-000004FORM 4

Feb 22, 2026

9.2 KB

Feb 24, 2026

0001830328-26-000005FORM 4

Feb 22, 2026

9.1 KB

Feb 24, 2026

0001647994-26-000004FORM 4

Feb 20, 2026

12.4 KB

10-K

Feb 23, 2026

0001326110-26-00003010-K

Dec 31, 2025

31.0 MB

144

Feb 23, 2026

0001950047-26-001638

—

6.3 KB

8-K

Feb 23, 2026

0001326110-26-0000258-K

Feb 23, 2026

336.1 KB

8-K

Feb 18, 2026

0001326110-26-0000188-K

Feb 18, 2026

233.5 KB

Feb 12, 2026

0001189020-26-000003FORM 4

Feb 10, 2026

23.8 KB

Feb 12, 2026

0001848899-26-000003FORM 4

Feb 10, 2026

9.1 KB

Feb 12, 2026

0001200637-26-000002FORM 4

Feb 10, 2026

390.3 KB

Feb 12, 2026

0001830328-26-000003FORM 4

Feb 10, 2026

9.1 KB

8-K

Jan 26, 2026

0001326110-26-0000148-K

Jan 23, 2026

169.8 KB

Jan 21, 2026

0001647994-26-000002FORM 4

Jan 20, 2026

416.9 KB

Jan 21, 2026

0001849739-26-000002FORM 4

Jan 16, 2026

423.7 KB

144

Jan 20, 2026

0001950047-26-000561

—

5.6 KB

144

Jan 20, 2026

0001949846-26-000009

—

4.5 KB

144

Jan 16, 2026

0001950047-26-000516

—

4.9 KB

8-K

Jan 15, 2026

0001326110-26-0000088-K

Jan 15, 2026

213.2 KB

8-K

Jan 14, 2026

0001326110-26-0000048-K

Jan 14, 2026

289.8 KB

Jan 5, 2026

0001848899-26-000001FORM 4

Dec 31, 2025

416.3 KB

25 filings shown

Filed	Form	Description
10/20/25	DEF 14C	DEF 14C	→
10/8/25	PRE 14C	PRE 14C	→
4/30/25	DEFA14A	DEFA14A	→
4/30/25	DEF 14A	DEF 14A	→
4/29/24	DEFA14A	DEFA14A	→
4/29/24	DEF 14A	DEF 14A	→
↓

ImmunityBio, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(518 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/26/26	4	4	→
2/24/26	4	4	→
2/24/26	4	4	→
2/24/26	4	4	→
2/24/26	4	4	→
2/24/26	4	4	→
↓

Filed	Form	Description
2/25/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
2/23/26	144	144	→
1/20/26	144	144	→
1/20/26	144	144	→
1/16/26	144	144	→
11/10/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
↓